2031년까지 북미 방사선 종양학 시장 전망 - 지역 분석 - 유형별(외부 빔 방사선 치료 및 내부 빔 방사선 치료) 및 응용 분야별(유방암, 전립선암, 폐암, 두경부암, 자궁경부암 및 기타)
암 유병률 증가로 북미 방사선 종양학 시장이 성장합니다.
암은 전 세계 사회에 상당한 영향을 미치는 흔한 건강 문제 중 하나입니다. 세계보건기구(WHO)에 따르면 암은 전 세계적으로 주요 사망 원인으로, 2023년에는 970만 명이 사망하고 2,000만 명이 새로운 암 환자가 발생했으며 2050년까지 약 3,500만 명이 새로운 암 환자가 될 것으로 예상됩니다. WHO 2024 보고서에 따르면 폐암은 전 세계적으로 가장 흔한 암이자 사망 원인이며, 그 뒤를 이어 대장암, 간암, 유방암, 위암이 전체 사망자의 각각 18.7%, 9.3%, 7.8%, 6.9%, 6.8%를 차지합니다.
암의 유병률과 발생률이 증가함에 따라 효과적인 치료 옵션에 대한 수요가 발생합니다. 방사선 요법은 암 세포를 죽이기 위해 X선, 감마선 등과 같은 고선량의 방사선을 활용하는 효과적인 결과를 보이는 암 환자를 위한 진화하는 치료 옵션 중 하나입니다. 방사선 요법은 암의 초기 단계에 사용되며 다양한 유형의 외부 빔 방사선 요법이 다양한 암을 치료하는 데 사용됩니다. 예를 들어, 근접치료는 유방암, 자궁경부암, 눈암, 전립선암, 두경부암 치료에 사용됩니다. 마찬가지로 전신 방사선 치료는 방사성 요오드라고도 하며 갑상선암 치료에 사용됩니다. 방사선 치료는 치료의 어느 시점에서나 사용할 수 있으며 수술, 화학 요법, 면역 요법 등과 같은 다른 치료와 결합할 수 있습니다. 따라서 암 유병률 증가와 종양학에서 방사선 요법의 발전은 방사선 종양학 시장의 성장을 촉진할 것으로 예상됩니다.
북미 방사선 종양학 시장 개요
방사선 요법은 미국 내 모든 암 환자에게 널리 제공되며 방사선 종양학자에 대한 필요성은 지속적으로 증가하고 있습니다. 이러한 전문가의 수도 개발된 의료 인프라로 인해 지속적으로 증가하고 있습니다. 그럼에도 불구하고 미국 임상 종양학 협회는 전 세계 암 환자의 약 3분의 2가 치료의 일환으로 방사선 요법을 받는 것으로 추정합니다. 2023년에 미국에서 100만 명이 넘는 암 환자가 매년 방사선 치료를 받을 것으로 예상됩니다. 정부와 의료 당국은 방사선 치료 도입을 장려하기 위해 여러 가지 이니셔티브를 취하고 있습니다. 2020년 6월, 미국 방사선 종양학회(ASTRO)는 비전이성 자궁 경부암에 대한 방사선 치료에 관한 새로운 임상 지침을 도입했습니다. 이 새로운 지침은 방사선 치료를 수행하기 위한 단계와 프로세스를 정확하게 구현하는 데 중점을 둡니다.
북미 방사선 종양학 시장 수익 및 2031년 예측(백만 달러)
북미 방사선 종양학 시장 세분화
북미 방사선 종양학 시장은 유형, 응용 분야 및 국가로 분류됩니다.
유형에 따라 북미 방사선 종양학 시장은 외부 빔 방사선 치료와 내부 빔 방사선 치료로 나뉩니다. 외부 빔 방사선 치료 부문은 2023년에 더 큰 시장 점유율을 차지했습니다.
적용 측면에서 북미 방사선 종양학 시장은 유방암, 전립선암, 폐암, 두경부암, 자궁경부암 등으로 분류됩니다. 유방암 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.
국가별로 북미 방사선 종양학 시장은 미국, 캐나다, 멕시코로 세분화됩니다. 미국은 2023년에 북미 방사선 종양학 시장 점유율을 지배했습니다.
Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide(Ion Beam Applications SA), Becton Dickinson and Co, Perspective Therapeutics Inc, NTP RADIOISOTOPES, Mallinckrodt Plc, Provision Healthcare, Curium은 북미 방사선 종양학 시장에서 운영되는 몇몇 선도 기업입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. North America Radiation Oncology Market Landscape
4.1 Overview
4.2 PEST Analysis
5. North America Radiation Oncology Market - Key Market Dynamics
5.1 Market Drivers:
5.1.1 Increasing Prevalence of Cancer
5.1.2 Initiatives to Support Developments in Radiation Oncology
5.2 Market Restraints
5.2.1 High Cost of Radiotherapy Equipment
5.3 Market Opportunities
5.3.1 Strategic Initiatives in Radiation Oncology
5.4 Future Trends
5.4.1 Technological Advancement in Radiation Oncology
5.5 Impact of Drivers and Restraints:
6. Radiation Oncology Market - North America Market Analysis
6.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031
7. North America Radiation Oncology Market Analysis - by Types
7.1 External Beam Radiation Therapy
7.1.1 Overview
7.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
7.2.1 Overview
7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8. North America Radiation Oncology Market Analysis - by Application
8.1 Breast Cancer
8.1.1 Overview
8.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Prostate Cancer
8.2.1 Overview
8.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Lung Cancer
8.3.1 Overview
8.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Head and Neck Cancer
8.4.1 Overview
8.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Cervical Cancer
8.5.1 Overview
8.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9. North America Radiation Oncology Market - Country Analysis
9.1 North America Radiation Oncology Market Overview
9.1.1 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
9.1.1.1 United States: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9.1.1.1.1 United States: Radiation Oncology Market Breakdown, by Types
9.1.1.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.1.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.1.1.4 United States: Radiation Oncology Market Breakdown, by Application
9.1.1.2 Canada: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9.1.1.2.1 Canada: Radiation Oncology Market Breakdown, by Types
9.1.1.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.1.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.1.2.4 Canada: Radiation Oncology Market Breakdown, by Application
9.1.1.3 Mexico: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9.1.1.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
9.1.1.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.1.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.1.3.4 Mexico: Radiation Oncology Market Breakdown, by Application
10. Radiation Oncology Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies in Radiation Oncology Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Varian Medical Systems Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Elekta AB
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Accuray Incorporated
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 IBA Worldwide (Ion Beam Applications SA)
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Becton Dickinson and Co
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Perspective Therapeutics Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 NTP RADIOISOTOPES
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Mallinckrodt Plc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Provision Healthcare
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Curium
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. North America Radiation Oncology Market Segmentation
Table 2. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 3. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 4. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 5. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 6. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 7. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 8. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 9. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 11. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 12. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 13. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. Recent Organic Growth Strategies in Radiation Oncology Market
Table 15. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 16. Glossary of Terms, Radiation Oncology Market
List of Figures
Figure 1. North America Radiation Oncology Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Radiation Oncology Market - Key Market Dynamics
Figure 4. Statistics at Glance, Global, 2022
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Radiation Oncology Market Revenue (US$ Million), 2021-2031
Figure 7. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
Figure 8. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
Figure 11. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. North America Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 18. North America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 19. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 20. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Growth Strategies in Radiation Oncology Market
- Varian Medical Systems Inc.
- Elekta AB.
- Accuray Incorporated.
- IBA Worldwide (Ion Beam Applications SA).
- Becton Dickinson and Co.
- Perspective Therapeutics Inc.
- NTP RADIOISOTOPES.
- Mallinckrodt Plc.
- Provision Healthcare.
- Curium.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America radiation oncology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America radiation oncology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America radiation oncology market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.